Suzhou New District Hi-Tech Industrial Co.Ltd(600736) ( Suzhou New District Hi-Tech Industrial Co.Ltd(600736) ), who harvested the triple board, revealed the mystery of the change on the evening of March 18. The company said that it is planning to implement cash capital increase for medical device industry companies, and realize holding and consolidation of trading objects. At present, the audit evaluation is under way, and the capital increase price, amount and shareholding ratio of the company after the capital increase have not been determined. The company has not signed an intentional agreement related to the capital increase with the medical device industry company or its current shareholders.
According to the announcement, Suzhou Su Hi Tech Group Co., Ltd., the current controlling shareholder of the medical device industry company, is the controlling shareholder of Suzhou New District Hi-Tech Industrial Co.Ltd(600736) and the capital increase will constitute a related party transaction in accordance with the provisions of the stock listing rules of Shanghai Stock Exchange. Audited by Suzhou Branch of Tianheng Certified Public Accountants (special general partnership), as of the end of 2020, the total assets of the medical device industry company were 2.289 billion yuan, and the net assets attributable to the shareholders of the parent company were 530 million yuan; In 2020, the medical device industry company realized an operating income of 593662 million yuan and a net profit attributable to the shareholders of the parent company of 8.9716 million yuan. Based on the audited financial data of the medical device industry company in 2020, it is estimated that this capital increase does not constitute a major asset reorganization specified in the administrative measures for major asset reorganization of listed companies.
Suzhou New District Hi-Tech Industrial Co.Ltd(600736) said that after the capital increase, the operating revenue, net profit and other financial indicators of the medical device industry company account for a small proportion of the company as a whole, which is not expected to have a significant impact on the company’s short-term performance and lead to significant changes in the company’s main business and fundamentals.
